METHOD FOR RAPID DIAGNOSIS OF THE SEVERITY OF PNEUMONIA IN COVID-19 Russian patent published in 2023 - IPC G01N33/68 G01N33/49 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to anesthesiology and resuscitation, therapy and pulmonology, and can be used for rapid diagnosis of the severity of pneumonia in COVID-19. Upon admission to the hospital in patients with pneumonia with COVID-19, the concentrations of ferritin, procalcitonin and C-reactive protein in the blood serum are determined. Additionally, the values of the variables are evaluated, the level of ferritin is up to 200 ng/ml - 1 point, the level of ferritin is from 201 to 500 ng/ml - 2 points, the level of ferritin is from 501 to 1000 ng/ml - 3 points, the level of ferritin is above 1001 ng/ml - 4 points; C-reactive protein level up to 18000 ng/ml - 1 point, C-reactive protein level from 18001 to 35000 ng/ml - 2 points, C-reactive protein level from 35001 to 44000 ng/ml - 3 points, C-reactive protein level protein above 44001 ng/ml - 4 points; procalcitonin level up to 1.0 ng/ml - 1 point, procalcitonin level from 1.1 to 1.5 ng/ml - 2 points, procalcitonin level from 1.6 to 3.0 ng/ml - 3 points, procalcitonin level is higher 3.1 ng/ml - 4 points. Upon receipt of the sum up to 4 points, pneumonia of mild severity is diagnosed, from 5 to 8 pneumonia of moderate severity is diagnosed, from 9 or more points severe pneumonia is diagnosed.

EFFECT: method provides an opportunity to increase the accuracy of express diagnostics of the severity of pneumonia in COVID-19 using a method available for use in practical health care by determining the concentration of ferritin, procalcitonin and C-reactive protein in blood serum in patients with pneumonia in COVID-19 with a scoring.

1 cl, 3 ex